The CloneLink
Platform
All threats made actionable for your prevention team. CloneLink only surfaces a signal when it’s clinically relevant. Then the platform informs the infection prevention team on what to do next.
Clonal Outbreak Detected
A new patient infection genomically matches a recent infection from another patient. This is a confirmed transmission chain. The outbreak is real and active.
Active Reservoir Found
A patient infection matches a prior environmental sample: i.e. air sample, drain swab, or high-touch area. The source of infection has been identified and located.
New Reservoir Found
A new environmental sample matches your patient infection database. No patient is infected yet, but one will be if the reservoir remains unaddressed.
A sequence that saves lives
Moving average length of stay by just 2% typically produces millions in operating profit.
In a prospective study, 109 of 114 identified transmission routes (96%) were successfully contained utilizing genomic intelligence.
3Every hospital-acquired infection (HAI) adds an average of ~7.8 days to a patient's stay, typically unreimbursed under fixed-rate DRG. Claryx prevents the infection, so the days never happen.
2Outbreak identification with zero guesswork
Sample. Sequence. Intervene. Before any new infections.
Claryx deploys continuous metagenomics sampling across ICUs, transplant, oncology and emergency departments
AeroScan samples the air continuously, and our team samples water and high-touch surfaces. Everything is sequenced at the Claryx lab, where CloneLink matches every infection and environmental sample at the strain level, showing whether a case is linked to another patient or to a source in the environment.
The result is a signal your team can act on. Intervention speed increases by over 15x, and every infection Claryx prevents frees ~7.8 days of bed capacity to serve new patients.
100%
Attributable
The resolution required to prove where an infection came from
1/20th
cost
Claryx’s breakthrough IP cuts certain sequencing costs twentyfold
Simple steps,from sample to signal
Through genomic sequencing, we build a digital twin of your hospital microbiome.
Frequently asked Questions
We have all your answers.
Claryx doesn’t replace your existing program; we empower it. Your IPC team is already working tirelessly. We provide the genomic signal that highlights exactly where to focus, so less time is lost chasing coincidences and real transmission chains become the priority.
The opposite. A documented, genomics-driven investigation protocol is your strongest legal defense. Hospitals have a reasonable duty of care mandate. The question is whether you acted systematically once signals appeared. Claryx makes that case decisively.
CloneLink filters all environmental data through patient infections first. Nothing surfaces unless it is clinically relevant. By eliminating fasle investigations, this frees the IPC team to focus on what matters most.
Every hospital-acquired infection extends a patient's stay by an average of ~7.8 days, which your hospital typically absorbs at cost with zero additional reimbursement. Reducing average length of stay (LoS) by just 2% at a standard hospital produces millions in incremental operating profit.
Talk To The Claryx Team
The Hospital Immune System